22 results
Thumbnail

D2.44 - Subjective assessment of sleep quality in adult patients with hereditary angioedema

Thumbnail

D2.47 - Unmasking Melkersson-Rosenthal Syndrome: Diagnostic Challenges in a Patinent Pressenting With Angioedema

Thumbnail

D2.43 - Hereditary Angioedema Can Hit at Any Age: A Case Report in Egypt

Thumbnail

D2.45 - Fixed Drug Eruption Due to Fenofibrate Hypersensitivity

Thumbnail

D2.46 - Patient with the overlap of Hereditary angioedema and Chronic spontaneous urticaria

Thumbnail

D2.48 - When Treatment Becomes the Cause: Allergic Contact Dermatitis to Topical Corticosteroids

Thumbnail

D2.50 - When Angioedema Is Not Angioedema: Orofacial Sarcoidosis Mimicking Refractory Facial Swelling

Thumbnail

D2.51 - Contact dermatitis due to continuous glucose monitoring sensors: limitations of standard patch testing

Thumbnail

D2.53 - Impact of Smoking on the Clinical and Allergological Profile of Allergic Contact Dermatitis: An 8-Year Analytical Study

Thumbnail

D2.54 - Correlation Between IgE Anti-Thyroid Peroxidase And Chronic Spontaneous Urticaria

Thumbnail

D2.55 - Allergic contact dermatitis and cross-sensitization after laser-assisted 5-aminolevulinic acid PDT

Thumbnail

D2.56 - Regionally Adapted Patch Test Panels Improve Diagnostic Resolution by Revealing Hidden Polysensitization in Allergic Contact Dermatitis

Thumbnail

D3.385 - A Synthetic Serum Comprising Human IgE Monoclonal Antibodies to Peanut Allergens

Thumbnail

D3.386 - Prevalence and immune mechanisms of rheumatoid arthritis in Kyrgyz highland residents

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child